Valuation : EirGenix Inc.

Market Cap 14.31B 454M 391M 368M 335M 627M 43.2B 630M 4.36B 1.69B 22.01B 1.7B 1.67B 69.73B P/E 2026 *
-31.7x
P/E 2027 * 84.6x
Enterprise Value 13.06B 414M 357M 336M 306M 572M 39.44B 575M 3.98B 1.54B 20.09B 1.56B 1.52B 63.65B EV / Sales 2026 *
8.86x
EV / Sales 2027 * 5.75x
Free-Float
59.94%
Yield 2026 *
-
Yield 2027 * -
1 day-0.62%
1 week-1.24%
Current month-0.52%
1 month-0.62%
3 months+6.44%
6 months-15.96%
Current year-22.37%
1 week 47.05
Extreme 47.05
49.4
1 month 47.05
Extreme 47.05
53
Current year 40.15
Extreme 40.15
67.6
1 year 40.15
Extreme 40.15
84.3
3 years 40.15
Extreme 40.15
111
5 years 40.15
Extreme 40.15
163.5
10 years 21.55
Extreme 21.55
195
Manager TitleAgeSince
Chief Executive Officer - 01/04/2013
Director of Finance/CFO - 03/05/2016
Corporate Officer/Principal - 20/05/2019
Director TitleAgeSince
Director/Board Member - 14/06/2013
Director/Board Member - 13/09/2016
Chairman - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%-1.24%-24.57%-48.66% 457M
-1.65%-5.80%+42.95%-4.67% 80.65B
-1.00%-2.50%-19.26%-37.42% 59.12B
-0.50%-10.12%+450.39%+26.47% 54.14B
-2.00%-5.20%-11.09%+27.83% 50.1B
-1.42%-8.61%-3.21%+144.72% 45.33B
+1.77%-4.65%+50.11%-17.32% 31.14B
-1.75%-3.33%+43.47%+92.11% 25.54B
-3.92%-7.32%-6.49%+166.90% 21.8B
-0.99%-4.61%+62.88%+97.84% 16.06B
Average -1.20%-3.44%+58.52%+44.78% 38.43B
Weighted average by Cap. -1.23%-3.84%+76.85%+35.90%

Financials

2026 *2027 *
Net sales 1.47B 46.78M 40.26M 37.91M 34.54M 64.62M 4.45B 64.88M 449M 174M 2.27B 176M 172M 7.18B 2.34B 74.36M 63.99M 60.25M 54.9M 103M 7.08B 103M 714M 276M 3.6B 279M 273M 11.42B
Net income -458M -14.54M -12.51M -11.78M -10.73M -20.08M -1.38B -20.16M -140M -53.95M -705M -54.58M -53.4M -2.23B 172M 5.46M 4.7M 4.42M 4.03M 7.54M 519M 7.57M 52.42M 20.26M 265M 20.5M 20.05M 838M
Net Debt -1.25B -39.58M -34.06M -32.07M -29.22M -54.67M -3.77B -54.89M -380M -147M -1.92B -149M -145M -6.08B -838M -26.6M -22.89M -21.55M -19.64M -36.74M -2.53B -36.89M -255M -98.71M -1.29B -99.87M -97.7M -4.08B
Logo EirGenix Inc.
EirGenix Inc is a Taiwan-based company primarily engaged in the development of antibody drugs and the manufacture of biopharmaceuticals. Its main businesses include the provision of Contract Development & Manufacturing Organization (CDMO) services, the construction of cell strain, the manufacture of clinical trial medicine, analytical science and protein identification, and PIC/S manufacturing plant to provide clinical trial drug production.
Employees
1,000
Date Price Change Volume
10/09/26 TWD 47.90 -0.62% 387,333
09/09/26 TWD 48.20 +1.58% 312,942
08/09/26 TWD 47.45 -0.11% 490,988
07/09/26 TWD 47.50 -1.14% 387,555
04/09/26 TWD 48.05 +0.31% 364,628
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
47.90TWD
Average target price
111.00TWD
Spread / Average Target
+131.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6589 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!